Printer Friendly
The Free Library
19,573,952 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

ACADIA Pharmaceuticals Announces Exercise of Over-Allotment by Underwriters.


SAN DIEGO -- ACADIA Acadia (əkā`dēə), Fr. Acadie, region and former French colony, E Canada, encompassing modern Nova Scotia but also New Brunswick, Prince Edward Island, and coastal areas of E Maine. After an abortive 1604 settlement of St.  Pharmaceuticals Inc. (Nasdaq:ACAD ACAD Academy
ACAD Academic
ACAD AutoCAD (design/drafting development software by Autodesk)
ACAD Acadia National Park (US National Park Service)
ACAD Atherosclerotic Coronary Artery Disease
) announced today that the underwriters have exercised in full their over-allotment option to purchase 862,500 shares of the Company's common stock, in connection with its public offering that priced on April 4, 2007. Including the over-allotment shares being purchased, the offering totaled 6,612,500 shares at a public offering price of $15.50 per share, resulting in aggregate net proceeds Net Proceeds

The amount received after all costs are deducted from the sale of a piece of property or security.

Notes:
In the case of an investor selling a security, net proceeds represent the proceeds from the sale minus any trading costs (i.e. commissions).
 to ACADIA of approximately $96.1 million after deducting underwriting discounts and commissions and estimated offering expenses.

The book-running managers for the offering are Banc of America Securities LLC (Logical Link Control) See "LANs" under data link protocol.

LLC - Logical Link Control
 and Lehman Brothers Inc., the co-lead manager is Deutsche Bank Securities Inc., and the co-managers are Piper Jaffray & Co., JMP JMP Jump
JMP Java Memory Profiler
JMP Joint Manpower Program
JMP Joint Management Plan
JMP Joint Marketing Program
JMP JCL Manipulation Program
JMP Joint Mission Planning (US DoD)
JMP Joint Military Program
 Securities LLC and Rodman & Renshaw, LLC.

A registration statement relating to these securities was filed and has been declared effective by the Securities and Exchange Commission. This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities, in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. The offering of these securities may be made only by means of the prospectus supplement, related prospectus and any supplemental information relating to the offering. You may obtain copies of the prospectus supplement and related prospectus by contacting Banc of America Securities LLC, Capital Markets (Prospectus Fulfillment) by e-mail to dg.prospectus_distribution@bofasecurities.com or by mail to Banc of America Securities LLC, Capital Markets Operations, 100 West 33rd Street, 3rd Floor, New York New York, state, United States
New York, Middle Atlantic state of the United States. It is bordered by Vermont, Massachusetts, Connecticut, and the Atlantic Ocean (E), New Jersey and Pennsylvania (S), Lakes Erie and Ontario and the Canadian province of
, NY 10001 and Lehman Brothers Inc. by e-mail to qiana.smith@broadridge.com or by fax to (631) 254-7268 or by mail to Lehman Brothers, c/o Qiana Smith, Broadridge, Prospectus Fulfillment, 1155 Long Island Avenue, Edgewood, NY 11717.

ACADIA Pharmaceuticals is a biopharmaceutical company with its corporate headquarters located in San Diego, California “San Diego” redirects here. For other uses, see San Diego (disambiguation).
San Diego is a coastal Southern California city located in the southwestern corner of the continental United States. As of 2006, the city has a population of 1,256,951.
 and research and development operations in both San Diego and Malmo, Sweden.
COPYRIGHT 2007 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2007, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Apr 20, 2007
Words:340
Previous Article:DPL Announces Timing of First Quarter Earnings Release, Webcast Conference Call.
Next Article:Flint Group to Acquire Day International.
Topics:



Related Articles
Human Genome Sciences Announces Exercise of Overallotment Option.
Glyko Biomedical Ltd.'s 22%-Owned Affiliate, BioMarin Completes $96.6 Million Public Offering of Common Stock.
MethylGene Announces Exercise of Over-Allotment Option.
Company Watch - Continental Airlines.
Aradigm Closes Offering of Common Stock.
ACADIA Pharmaceuticals Announces Proposed Public Stock Offering.
ACADIA Pharmaceuticals Announces Pricing of Public Stock Offering.
Altus Pharmaceuticals Announces Public Offering of Common Stock.
Altus Pharmaceuticals Announces Pricing of Public Offering of 6,000,000 Shares of Common Stock.
Altus Pharmaceuticals Announces Closing of $88.5 Million Public Offering.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles